- Instrument
- Reagents & Kits
- Software
Blood Screening Market size is valued at USD 2,225 million in 2022 and is expected to grow at a CAGR of 8.6% from 2023-2029. Blood screening is defined as various tests done on blood samples for the diagnosis of numerous diseases such as AIDS, syphilis, hepatitis treatment, and other clinical circumstances such as pregnancy. It aids in monitoring diseases and avoiding health issues and a variety of other conditions such as cancer and infections. Blood donor screening is the protection mechanism employed against the spread of infection before blood donation. The global market provides a detailed overview of the Blood Screening market, and that can be segmented by product, by technology, and by end user. By product, the Blood Screening market has been segmented into Instrument, Reagents & Kits, and Software. The reagents & kits segment is likely to be the largest and fastest-growing segment in terms of product. The rise of this segment is mainly due to an increase in blood transfusion events, because of which there is more repeated use and consumption of reagents & kits in blood screening process. Based on Technology, the Nucleic Acid Amplification, Elisa, Rapid test, NGS, and Western Blotting. Among these, the Nucleic Acid Amplification segment is expected to have the fastest-growing market during the forecast period 2022-2028. The major factor for rising of this segment is the growing acceptance of nucleic acid amplification technology due to its increased sensitivity over other blood screening techniques. Apart from this, the increasing number of blood donations can also drive the growth of this segment. Based on the End user, the Blood Screening market is segmented into Blood banks and Hospitals. The Blood banks segment is expected to have a significant share in 2022. The rise of this segment is mainly because of the increasing number of organ transplants.
Blood Screening Market Key Developments:
- In September 2021, Roche Diagnostics acquired TIB Molbiol Group to expand its business in molecular diagnostics.
- In February 2020, BD (US) acquired NAT Diagnostics (US), to enhance a molecular diagnostic platform for POC testing.
Blood Screening Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.6%
Largest Market
North America
Fastest Growing Market
Europe
Blood Screening Market Dynamics
The increasing incidence rate of infectious diseases is anticipated to propel market growth over the forecast years. Moreover, the growing awareness about blood donation and the protection of donated blood are burgeoning the market growth over the forecast years.
North American Got Significant Share
Blood Screening Market Regional Analysis
North American market is expected to witness the highest market share during the forecast period
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The Blood screening market provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The Blood screening market covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The Blood screening market outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The Blood screening market tracks recent innovations, key developments, and start-up details that are actively working in the market
- The Blood screening market provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Blood Screening Market Segmentation
By Product
By Technology
- Nucleic Acid Amplification
- Elisa
- Rapid Test
- NGS
- Western Blotting
By End User
- Blood Banks
- Hospitals
By Geography
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The blood screening market is projected to expand at a CAGR of 8.6% during the forecast period
Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories Inc., Grifols, Siemens AG, Beckman Coulter Inc.
North American is the fastest-growing region for blood screening market
| 1.Executive Summary |
| 2.Global Blood Screening Market Introduction |
| 2.1.Global Blood Screening Market - Taxonomy |
| 2.2.Global Blood Screening Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Technology |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Blood Screening Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Blood Screening Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Blood Screening Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Instrument |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Reagents & Kits |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Blood Screening Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Nucleic Acid Amplification |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Elisa |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Rapid Test |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. NGS |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Western Blotting |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Blood Screening Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Blood Banks |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global Blood Screening Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Blood Screening Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Instrument |
| 9.1.2.Reagents & Kits |
| 9.1.3.Software |
| 9.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Nucleic Acid Amplification |
| 9.2.2.Elisa |
| 9.2.3.Rapid Test |
| 9.2.4.NGS |
| 9.2.5.Western Blotting |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Blood Banks |
| 9.3.2.Hospitals |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Blood Screening Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Instrument |
| 10.1.2.Reagents & Kits |
| 10.1.3.Software |
| 10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Nucleic Acid Amplification |
| 10.2.2.Elisa |
| 10.2.3.Rapid Test |
| 10.2.4.NGS |
| 10.2.5.Western Blotting |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Blood Banks |
| 10.3.2.Hospitals |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Blood Screening Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Instrument |
| 11.1.2.Reagents & Kits |
| 11.1.3.Software |
| 11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Nucleic Acid Amplification |
| 11.2.2.Elisa |
| 11.2.3.Rapid Test |
| 11.2.4.NGS |
| 11.2.5.Western Blotting |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Blood Banks |
| 11.3.2.Hospitals |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Blood Screening Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Instrument |
| 12.1.2.Reagents & Kits |
| 12.1.3.Software |
| 12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Nucleic Acid Amplification |
| 12.2.2.Elisa |
| 12.2.3.Rapid Test |
| 12.2.4.NGS |
| 12.2.5.Western Blotting |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Blood Banks |
| 12.3.2.Hospitals |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Blood Screening Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Instrument |
| 13.1.2.Reagents & Kits |
| 13.1.3.Software |
| 13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Nucleic Acid Amplification |
| 13.2.2.Elisa |
| 13.2.3.Rapid Test |
| 13.2.4.NGS |
| 13.2.5.Western Blotting |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Blood Banks |
| 13.3.2.Hospitals |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Becton, Dickinson and Company |
| 14.2.2.Thermo Fisher Scientific Inc. |
| 14.2.3.Danaher Corporation |
| 14.2.4.Abbott Laboratories |
| 14.2.5.Bio-Rad Laboratories Inc. |
| 14.2.6.Grifols |
| 14.2.7.Siemens AG |
| 14.2.8.Beckman Coulter Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Grifols
- Siemens AG
- Beckman Coulter Inc.